Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality Fujian Medical University Union Hospital, Fuzhou, Fujian Fujian Cancer Hospital, Fuzhou, Fujian Sun-Yat Sen University Cancer Center, Guangzhou, Guangdong The First affiliated hospital, Sun Yat-sen University, Guangzhou, Guangdong Henan Provincial Oncology Hospital, Zhengzhou, Henan Union Hospital medical college Huazhong University of Science and Technology, Wuhan, Hubei Hunan Provincial Oncology Hospital, Changsha, Hunan Zhejiang Provincial Oncology Hospital, Hangzhou, Zhejiang